Related references
Note: Only part of the references are listed.A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease
G. D. Naismith et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort
Emanuel Burri et al.
CLINICA CHIMICA ACTA (2013)
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2013)
Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
Martine De Vos et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mucosal Healing in Inflammatory Bowel Disease
Mark T. Osterman
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease
Triana Lobatón et al.
Journal of Crohns & Colitis (2013)
Rapid fecal calprotectin correlates with clinical and endoscopic severity of inflammatory bowel diseases
Antonio Tursi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care
Polychronis Pavlidis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Evaluation of fecal calprotectin in Campylobacter concisus and Campylobacter jejuni/coli gastroenteritis
Hans Linde Nielsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy
John L. Wallace
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease
Paula Rodriguez-Otero et al.
BLOOD (2012)
Ruling out IBD: Estimation of the possible economic effects of pre-endoscopic screening with F-calprotectin
Mirja Mindemark et al.
CLINICAL BIOCHEMISTRY (2012)
Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) Study
Liselotte Kok et al.
CLINICAL CHEMISTRY (2012)
Biomarkers in Diverticular Diseases of the Colon
Antonio Tursi
DIGESTIVE DISEASES (2012)
A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study
Fabrizio Parente et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
Pauliina Molander et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers
Alain M. Schoepfer et al.
JOURNAL OF CROHNS & COLITIS (2012)
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis
M. De Vos et al.
JOURNAL OF CROHNS & COLITIS (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Fecal Calprotectin as a Correlative Marker in Clinical Severity of Infectious Diarrhea and Usefulness in Evaluating Bacterial or Viral Pathogens in Children
Chien-Chang Chen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Fecal calprotectin concentration is increased in children with celiac disease: relation with histopathological findings
Necati Balamtekin et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2012)
Local calprotectin production in colorectal cancer and polyps-active neutrophil recruitment in carcinogenesis
Kim Luley et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot study
Michael Wagner et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Stool Calprotectin Monitoring After Small Intestine Transplantation
David F. Mercer et al.
TRANSPLANTATION (2011)
Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
Anssi Hamalainen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis
Josef Sykora et al.
ACTA PAEDIATRICA (2010)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
Dario Sorrentino et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study
Gianmichele Meucci et al.
DIGESTIVE AND LIVER DISEASE (2010)
Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study
Lamia Kallel et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
Valle Garcia-Sanchez et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Faecal calprotectin in children with clinically quiescent inflammatory bowel disease
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Can chronic gastritis cause an increase in fecal calprotectin concentrations?
Massimo Montalto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Review article: the current and evolving treatment of colonic diverticular disease
A. Tursi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
G. T. Ho et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease
C. A. Lamb et al.
BRITISH JOURNAL OF SURGERY (2009)
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease
J. P. Gisbert et al.
DIGESTIVE AND LIVER DISEASE (2009)
Ulcerative Colitis: Correlation of the Rachmilewitz Endoscopic Activity Index with Fecal Calprotectin, Clinical Activity, C-reactive Protein, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2009)
Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2009)
Faecal calprotectin in colonic diverticular disease: a case-control study
Antonio Tursi et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy
Laurence Maiden
JOURNAL OF GASTROENTEROLOGY (2009)
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings
T. Sipponen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Prospective Multicenter Study Evaluating Fecal Calprotectin in Adult Acute Bacterial Diarrhea
Yogesh M. Shastri et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth
Massimo Montalto et al.
DIGESTIVE DISEASES (2008)
Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases
A. Diamanti et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Dorota Walkiewicz et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal calprotectin level measurements in small bowel allograft monitoring: A pilot study
Edip Akpinar et al.
TRANSPLANTATION (2008)
Assessment of endoscopic activity lndex and biological lnflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level
Marie-Arrhelle Denis et al.
INFLAMMATORY BOWEL DISEASES (2007)
Calprotectin - A novel noninvasive marker for intestinal allograft monitoring
Debra Sudan et al.
ANNALS OF SURGERY (2007)
Metabolic and inflammatory faecal markers in collagenous colitis
Signe Wildt et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease
Marco Scarpa et al.
DISEASES OF THE COLON & RECTUM (2007)
Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy
Alexander C. von Roon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Faecal calprotectin concentrations in untreated coeliac patients
Massimo Montalto et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations
Massimo Montalto et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis
J Langhorst et al.
INFLAMMATORY BOWEL DISEASES (2005)
A quantitative analysis of NSAID-Induced small bowel pathology by capsule enteroscopy
L Maiden et al.
GASTROENTEROLOGY (2005)
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
F Costa et al.
GUT (2005)
Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT)
G Hoff et al.
GUT (2004)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease
JA Tibble et al.
GASTROENTEROLOGY (2002)
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
CB Summerton et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Age-dependent variations in fecal calprotectin concentrations in children
B Golden et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma
J Tibble et al.
GUT (2001)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
Share Paper
